{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:57Z","timestamp":1793126037706,"version":"4.5.0"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jconrel.2026.115474","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:22:38Z","timestamp":1792682558000},"page":"115474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis"],"prefix":"10.1016","volume":"400","author":[{"given":"Zih-Chan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kuo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alalaiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115474_bb0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","article-title":"Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems","volume":"25","author":"Rapalli","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115474_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115429","article-title":"Advancing insights into psoriasis: from pathogenesis to current and emerging therapies","volume":"165","author":"Gon\u00e7alves","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115021","article-title":"Psoriasis unveiled: the cellular ballet, molecular symphony, and genetic puzzle","volume":"161","author":"Sharma","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0020","article-title":"Interventions in cytokine signaling: novel horizons for psoriasis treatment","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0025","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular mechanisms of psoriasis pathogenesis: a systemic review","volume":"16","author":"Wu","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/PTT.S516109","article-title":"Predictors of quality of life in psoriasis patients: insights from a cross-sectional study","volume":"15","author":"Walniczek","year":"2025","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0040","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s13555-025-01423-0","article-title":"Biologics for the treatment of moderate-to-severe plaque pasoriasis: a systematic review and network meta-analysis","volume":"15","author":"Lebwohl","year":"2025","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4254\/wjh.v15.i5.699","article-title":"Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index","volume":"15","author":"Castiella","year":"2023","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PTT.S328575","article-title":"Biologics in psoriasis: updated perspectives on long-term safety and risk management","volume":"12","author":"Al-Janabi","year":"2022","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0055","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2022.5270","article-title":"Psoriasis","volume":"327","author":"Walter","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2026.115474_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00228-025-03986-5","article-title":"A review of current therapeutics for psoriasis: systemic and topical use of non-biological drugs","volume":"82","author":"G\u00fcn","year":"2026","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0065","first-page":"1313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0070","article-title":"A complex molecular landscape to drug delivery concept for achieving precise therapy in psoriasis","volume":"22","author":"Yadav","year":"2024","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115474_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2200570","article-title":"Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness","volume":"34","author":"Ninosu","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jconrel.2026.115474_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040535","article-title":"Delivery of DNA-based therapeutics for treatment of chronic diseases","volume":"16","author":"Sussman","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-025-00756-8","article-title":"Immunogenicity of gene and cell therapies","volume":"40","author":"Hofman","year":"2026","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2026.115474_bb0090","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2147\/DDDT.S447780","article-title":"RNA-based antipsoriatic gene therapy: an updated review focusing on evidence from animal models","volume":"18","author":"Lin","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030283","article-title":"Topical therapy in psoriasis: clinical benefits, advances in novel drug delivery strategies, and gene therapy regimen","volume":"17","author":"Zhu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103753","article-title":"Advances in RNA therapy for the treatment of autoimmune diseases","volume":"24","author":"Zhang","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2026.115474_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2017.12.014","article-title":"Current and future technological advances in transdermal gene delivery","volume":"127","author":"Chen","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115474_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06219-6","article-title":"Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics?","volume":"23","author":"Bhat","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0115","article-title":"Advancements in skin-mediated drug delivery: mechanisms, techniques, and applications","volume":"13","author":"Lee","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081934","article-title":"Contribution of the environment, epigenetic mechanisms and non-coding RNAs in psoriasis","volume":"10","author":"Antonatos","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115474_bb0125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115474_bb0130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/ijd.13956","article-title":"The associations between psychological stress and psoriasis: a systematic review","volume":"57","author":"Stewart","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1346-8138.16733","article-title":"Clinical characteristics of patients with psoriasis with family history: a multicenter observational study","volume":"50","author":"Ohata","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115474_bb0145","first-page":"18","article-title":"Psoriasis risk factors and triggers","volume":"102","author":"Lee","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.jconrel.2026.115474_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis\u2013current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clicom.2024.12.001","article-title":"Role of skin antimicrobial peptides in the pathogenesis of psoriasis, atopic dermatitis and hidradenitis suppurative: highlights on dermcidin","volume":"7","author":"Beliz\u00e1rio","year":"2025","journal-title":"Clin. Immunol. Commun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0165","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jid.2022.10.017","article-title":"Cathelicidin antimicrobial peptide LL37 induces toll-like receptor 8 and amplifies IL-36\u03b3 and IL-17C in human keratinocytes","volume":"143","author":"Miura","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186791","article-title":"Psoriasis and antimicrobial peptides","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-021-02207-0","article-title":"Macrophages in dermatology: pathogenic roles and targeted therapeutics","volume":"314","author":"Kuraitis","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jconrel.2026.115474_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1286344","article-title":"Crosstalk: keratinocytes and immune cells in psoriasis","volume":"14","author":"Kamata","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jid.2021.04.014","article-title":"Neutrophils as drivers of immune dysregulation in autoimmune diseases with skin manifestations","volume":"142","author":"Nakabo","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0190","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-025-67917-9","article-title":"Dynamic neutrophil-keratinocyte communication network centered on IL-36\/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis","volume":"17","author":"Jiang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2020.03.023","article-title":"Beyond repression of Nrf2: an update on Keap1","volume":"157","author":"Kopacz","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176206","article-title":"Oxidative stress as an important contributor to the pathogenesis of psoriasis","volume":"21","author":"Ple\u0144kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0210","article-title":"Types of psoriasis and their effects on the immune system","volume":"14","author":"Dhabale","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2026.115474_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177083","article-title":"RNAi in psoriasis: a melodic exploration of miRNA, shRNA, and amiRNA with a spotlight on siRNA","volume":"985","author":"Purewal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.jconrel.2026.115474_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea6079","article-title":"MiRNA gene mutations commonly disrupt the proper functioning of miRNA genes","volume":"12","author":"Machowska","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0235","article-title":"MiRNAs flowing up and down: the concerto of psoriasis","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150081","article-title":"Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis","volume":"990","author":"Singh","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.jconrel.2026.115474_bb0245","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/exd.14871","article-title":"The role of microRNA in psoriasis: a review","volume":"32","author":"Jiang","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0250","first-page":"367","article-title":"Understanding psoriasis: role of miRNAs","volume":"9","author":"Timis","year":"2018","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.jconrel.2026.115474_bb0255","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jid.2023.10.042","article-title":"Neutrophil-derived microRNA-1290 promotes keratinocyte proliferation in psoriasis","volume":"144","author":"Higashi","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104609","article-title":"Achieving durable psoriasis remission with nucleic acid therapeutics","volume":"31","author":"Zhou","year":"2026","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115474_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: an emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0270","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: immunological functions and potential biomarkers","volume":"26","author":"Liu","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0275","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1523-1747.2000.00143.x","article-title":"Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides","volume":"115","author":"Mehta","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(01)00133-4","article-title":"Antisense oligonucleotides in cutaneous therapy","volume":"90","author":"Wraight","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0285","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2024.12.002","article-title":"Enhancing non-viral DNA delivery systems: recent advances in improving efficiency and target specificity","volume":"378","author":"Hosseini-Kharat","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000314154","article-title":"A novel transdermal plasmid-dimethylsulfoxide delivery technique for treatment of psoriasis","volume":"221","author":"Zhang","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jconrel.2026.115474_bb0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5021\/ad.2015.27.2.121","article-title":"Retinoic Acid promotes interleukin-4 plasmid-dimethylsulfoxide topical transdermal delivery for treatment of psoriasis","volume":"27","author":"Chen","year":"2015","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0300","doi-asserted-by":"crossref","first-page":"13159","DOI":"10.1073\/pnas.1108567108","article-title":"Male germ cells express abundant endogenous siRNAs","volume":"108","author":"Song","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115474_bb0305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/17425247.2023.2206646","article-title":"Small interfering RNA-based nanotherapeutics for treating skin-related diseases","volume":"20","author":"Chang","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0310","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/ITT.S458800","article-title":"Targeted siRNA therapy for psoriasis: translating preclinical potential into clinical treatments","volume":"13","author":"Zhao","year":"2024","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0315","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/kjm2.12034","article-title":"Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of ERK signaling pathway","volume":"35","author":"Chen","year":"2019","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146592","article-title":"Gene therapies in dermatological diseases: a breakthrough in treatment","volume":"26","author":"Lisi\u0144ska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0325","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/mt.2009.141","article-title":"Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model","volume":"17","author":"Jakobsen","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0330","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41419-022-05445-w","article-title":"Mesenchymal stem\/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis","volume":"13","author":"Ding","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115474_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178075","article-title":"siRNA nanodelivery systems in the treatment of skin diseases: research progress and clinical translation prospects","volume":"1005","author":"Jian","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0340","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.7150\/thno.98487","article-title":"Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries","volume":"14","author":"Yu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0345","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","article-title":"Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114218","article-title":"Novel TNF-\u03b1-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling","volume":"387","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0355","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","article-title":"MiRNA-based drugs: challenges and delivery strategies","volume":"109","author":"Wang","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081072","article-title":"Anti-inflammatory microRNAs for treating inflammatory skin diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115474_bb0365","first-page":"101","article-title":"Exosomal microRNA-based therapies for skin diseases","volume":"25","author":"Chen","year":"2023","journal-title":"Regen. Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ijd.17982","article-title":"MSC-derived secretome and exosomes in dermatology: mechanisms, therapeutic opportunities, and scientific challenges-a narrative review","volume":"65","author":"da Costa Pereira Cestari","year":"2026","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0375","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ame2.70076","article-title":"Advances in miRNA research: unraveling the complexities of gene regulation","volume":"8","author":"Zheng","year":"2025","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0380","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/anie.202003563","article-title":"Nucleic acid aptamers for molecular diagnostics and therapeutics: advances and perspectives","volume":"60","author":"Li","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115474_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136833","article-title":"New insights into aptamers: an alternative to antibodies in the detection of molecular biomarkers","volume":"25","author":"Domsicova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100103","article-title":"The potential of CRISPR-guided therapies in the dermatology clinic","volume":"2","author":"Bhat","year":"2022","journal-title":"JID Innov."},{"key":"10.1016\/j.jconrel.2026.115474_bb0395","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jconrel.2026.115474_bb0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jid.2018.06.191","article-title":"Keratinocyte expression of A20\/TNFAIP3 controls skin inflammation associated with atopic dermatitis and psoriasis","volume":"139","author":"Devos","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0405","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115474_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122818","article-title":"Improved topical drug delivery: role of permeation enhancers and advanced approaches","volume":"14","author":"Hmingthansanga","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0415","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41598-018-37900-0","article-title":"Effect of chemical permeation enhancers on skin permeability: in silico screening using molecular dynamics simulations","volume":"9","author":"Gupta","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115474_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070877","article-title":"Novel pharmaceutical strategies for enhancing skin penetration of biomacromolecules","volume":"15","author":"Zhang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115474_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acsabm.3c00659","article-title":"Transdermal properties of cell-penetrating peptides: applications and skin penetration mechanisms","volume":"7","author":"Shin","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb0430","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2017.11.013","article-title":"Towards topical microRNA-directed therapy for epidermal disorders","volume":"269","author":"Ross","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0435","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1021\/acs.biomac.8b00292","article-title":"Cell-penetrating peptide-patchy deformable polymeric nanovehicles with enhanced cellular uptake and transdermal delivery","volume":"19","author":"Park","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115474_bb0440","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1038\/s41598-018-26749-y","article-title":"Targeted delivery of cell penetrating peptide virus-like nanoparticles to skin cancer cells","volume":"8","author":"Gan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115474_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0450","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/acs.chemrev.6b00562","article-title":"Biological activity of ionic liquids and their application in pharmaceutics and medicine","volume":"117","author":"Egorova","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115474_bb0455","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.drudis.2019.09.018","article-title":"Ionic liquids: green and tailor-made solvents in drug delivery","volume":"25","author":"Huang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115474_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119031","article-title":"Novel skin permeation enhancers based on amino acid ester ionic liquid: design and permeation mechanism","volume":"576","author":"Zheng","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0465","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijbiomac.2022.04.050","article-title":"Insights into protein-ionic liquid interaction: a comprehensive overview on theoretical and experimental approaches","volume":"209","author":"Tarannum","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0470","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/tde.14.61","article-title":"Delivery and targeting of nanoparticles into hair follicles","volume":"5","author":"Fang","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15072002","article-title":"Methodologies to evaluate the hair follicle-targeted drug delivery provided by nanoparticles","volume":"15","author":"Pereira","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ncrna.2023.05.008","article-title":"Advances in transdermal siRNAs delivery: a review of current research progress","volume":"8","author":"Sufianov","year":"2023","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.jconrel.2026.115474_bb0485","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-026-04569-8","article-title":"Nanotechnology advances for psoriasis treatment and future prospects","volume":"21","author":"Hu","year":"2026","journal-title":"Discover Nano"},{"key":"10.1016\/j.jconrel.2026.115474_bb0490","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1021\/acsnano.2c07843","article-title":"Hyaluronic acid nanoparticles as a topical agent for treating psoriasis","volume":"16","author":"Lee","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115474_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101410","article-title":"Current overview of metal nanoparticles' synthesis, characterization, and biomedical applications, with a focus on silver and gold nanoparticles","volume":"16","author":"Burlec","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115474_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010204","article-title":"Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery","volume":"25","author":"Graczyk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115474_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179845","article-title":"An update on photodynamic therapy of psoriasis-current strategies and nanotechnology as a future perspective","volume":"23","author":"Makuch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0510","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00418-023-02182-9","article-title":"nanoGold and \u03bcGold inhibit autoimmune inflammation: a review","volume":"159","author":"Danscher","year":"2023","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0515","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1021\/acs.nanolett.1c02899","article-title":"Alkyl-terminated gold nanoparticles as a self-therapeutic treatment for psoriasis","volume":"21","author":"Han","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115474_bb0520","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00449-024-03058-5","article-title":"Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties","volume":"47","author":"Telange","year":"2024","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.jconrel.2026.115474_bb0525","article-title":"Mesoporous silica nanoparticle-based nanomedicine: preparation, functional modification, and theranostic applications","volume":"34","author":"Liu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115474_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151613","article-title":"Synergistic chemo-photodynamic therapy based on hollow mesoporous organosilica nanoparticles for reducing psoriasis-like inflammation","volume":"490","author":"Fan","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115474_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100132","article-title":"Recent advances in using liposomes for delivery of nucleic acid-based therapeutics","volume":"11","author":"Nsairat","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.jconrel.2026.115474_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107380","article-title":"Liposomes-in-hydrogel for topical drug delivery: mechanical, kinetic, and biological insights","volume":"113","author":"Braido","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0545","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/0115748855297829240227072642","article-title":"Liposome as a potential drug delivery system in addressing skin diseases: a review","volume":"20","author":"Malhotra","year":"2025","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.jconrel.2026.115474_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110322","article-title":"Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis","volume":"145","author":"Yadav","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2026.115474_bb0555","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/exd.12321","article-title":"Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies","volume":"23","author":"Bracke","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0560","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2016.01.042","article-title":"An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: proof-of-concept in the treatment of psoriasis","volume":"500","author":"Desmet","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020656","article-title":"Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications","volume":"15","author":"Akombaetwa","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101270","article-title":"SLNs and NLCs for skin applications: enhancing the bioavailability of natural bioactives","volume":"16","author":"Safta","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202506812","article-title":"Recent advances in lipid nanoparticles: nucleic acid therapeutics and targeting strategies","volume":"21","author":"Sarmah","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115474_bb0580","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/1061186X.2025.2544783","article-title":"Recent advancements in nanoparticle-based topical drug delivery systems for psoriasis treatment","volume":"34","author":"Mitra","year":"2026","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2026.115474_bb0585","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2217\/nnm.13.202","article-title":"Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques","volume":"9","author":"Marepally","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115474_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.jconrel.2026.115474_bb0595","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1039\/D2BM01521H","article-title":"Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via the Ly6 antigen for psoriasiform dermatitis alleviation","volume":"11","author":"Lin","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0600","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.7150\/thno.56995","article-title":"Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0605","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s44222-025-00347-w","article-title":"Dendrimer engineering to overcome delivery challenges of nucleic acids","volume":"3","author":"Ni","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115474_bb0610","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/macromol3020022","article-title":"Dendrimers: synthesis, encapsulation applications and specific interaction with the stratum corneum\u2014a review","volume":"3","author":"Bacha","year":"2023","journal-title":"Macromol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105792","article-title":"Poly(amidoamine) dendrimers a \u2018soft polymer\u2019 for topical application of resveratrol: ex-vivo and in-vivo study","volume":"97","author":"Singh","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0620","article-title":"Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies","volume":"628","author":"Silvestrini","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0625","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/17425247.2020.1819979","article-title":"Advances in lyotropic liquid crystal systems for skin drug delivery","volume":"17","author":"Silvestrini","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0630","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/acs.nanolett.7b05430","article-title":"Lipid-based liquid crystalline nanoparticles facilitate cytosolic delivery of siRNA via structural transformation","volume":"18","author":"He","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115474_bb0635","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.apsb.2021.02.013","article-title":"Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles","volume":"11","author":"Yaghmur","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115474_bb0640","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/anie.201804067","article-title":"Cubosomes: the next generation of smart lipid nanoparticles?","volume":"58","author":"Barriga","year":"2019","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115474_bb0645","article-title":"Leveraging nature's nanocarriers: translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0650","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.2147\/IJN.S502591","article-title":"Extracellular vesicles: a review of their therapeutic potentials, sources, biodistribution, and administration routes","volume":"20","author":"Su","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115474_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202400623","article-title":"The potential for extracellular vesicles in nanomedicine: a review of recent advancements and challenges ahead","volume":"9","author":"Ebrahimi","year":"2025","journal-title":"Adv. Biol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121586","article-title":"The role of extracellular vesicles in the development and treatment of psoriasis: narrative review","volume":"16","author":"Tang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0665","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115474_bb0670","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/acsabm.9b01197","article-title":"Self-assembled DNA nanostructures-based nanocarriers enabled functional nucleic acids delivery","volume":"3","author":"Huang","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400810","article-title":"Framework nucleic acids: innovative tools for cellular sensing and therapeutics","volume":"26","author":"Zhang","year":"2025","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2026.115474_bb0680","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/acs.accounts.5c00775","article-title":"Spherical nucleic acids: turning synthetic advances and fundamental discovery into translational breakthroughs in chemistry, materials development, biology, and medicine","volume":"59","author":"Forsyth","year":"2026","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115474_bb0685","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1039\/D3NR05971E","article-title":"Spherical nucleic acids: emerging amplifiers for therapeutic nanoplatforms","volume":"16","author":"Tao","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115474_bb0690","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.1305804110","article-title":"Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110360","article-title":"Gene regulation using spherical nucleic acid to treat skin disorders","volume":"13","author":"Holmes","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115474_bb0700","doi-asserted-by":"crossref","first-page":"18658","DOI":"10.1021\/acsami.5c25947","article-title":"Rational design of spherical nucleic acids: expanding horizons for precision nucleic acid therapy","volume":"18","author":"Li","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115474_bb0705","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/cbe.4c00164","article-title":"Nucleic acid framework-enabled spatial organization for biological applications","volume":"2","author":"Zhang","year":"2024","journal-title":"Chem. Bio. Eng."},{"key":"10.1016\/j.jconrel.2026.115474_bb0710","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41467-019-09029-9","article-title":"Framework nucleic acids as programmable carrier for transdermal drug delivery","volume":"10","author":"Wiraja","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0715","article-title":"How physical techniques improve the transdermal permeation of therapeutics: a review","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jconrel.2026.115474_bb0720","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/ics.12824","article-title":"Iontophoresis in dermal delivery: a review of applications in dermato-cosmetic and aesthetic sciences","volume":"45","author":"Liatsopoulou","year":"2023","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0725","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/pharmaceutics14030525","article-title":"Iontophoresis of biological macromolecular drugs","volume":"14","author":"Hasan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115474_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121693","article-title":"Microneedle and iontophoresis mediated delivery of methotrexate into and across healthy and psoriatic skin","volume":"618","author":"Vora","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0735","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/ajd.13228","article-title":"Iontophoretic delivery of methotrexate in the treatment of palmar psoriasis: a randomised controlled study","volume":"61","author":"Chandrappa","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0740","article-title":"Low-frequency sonophoresis: a promising strategy for enhanced transdermal delivery","volume":"2024","author":"Marathe","year":"2024","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125539","article-title":"Development of a dual-frequency sonophoresis for enhanced skin permeability and efficient drug delivery","volume":"675","author":"Alsaadi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0750","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41596-019-0125-y","article-title":"Nonviral ultrasound-mediated gene delivery in small and large animal models","volume":"14","author":"Bez","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.115474_bb0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1309-z","article-title":"Enhanced transdermal drug delivery by sonophoresis and simultaneous application of sonophoresis and iontophoresis","volume":"20","author":"Park","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115474_bb0760","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/macromol4020019","article-title":"Microneedles' device: design, fabrication, and applications","volume":"4","author":"Oliveira","year":"2024","journal-title":"Macromol"},{"key":"10.1016\/j.jconrel.2026.115474_bb0765","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202504294","article-title":"Microneedle technology in psoriasis management: mechanistic insights, technological innovation, clinical progress, and challenges","volume":"15","author":"Moawad","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb0770","doi-asserted-by":"crossref","first-page":"94907639","DOI":"10.26599\/NR.2025.94907639","article-title":"Revolutionizing psoriasis care: microneedle innovations in treatment and diagnosis","volume":"18","author":"Hu","year":"2025","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115474_bb0775","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2021.05.009","article-title":"Microneedles for gene and drug delivery in skin cancer therapy","volume":"335","author":"Zhi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0780","doi-asserted-by":"crossref","first-page":"12951","DOI":"10.1007\/s00210-025-04117-8","article-title":"Polymeric microneedle advancements in macromolecule drug delivery: current trends, challenges, and future perspectives","volume":"398","author":"Kenchegowda","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0785","first-page":"67","article-title":"Transdermal drug delivery systems: a focused review of the physical methods of permeation enhancement","volume":"14","author":"Vaseem","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2026.115474_bb0790","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425247.2019.1649655","article-title":"Laser ablation and topical drug delivery: a review of recent advances","volume":"16","author":"Hsiao","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0795","article-title":"Laser-mediated solutions: breaking barriers in transdermal drug delivery","volume":"25","author":"Khaschechi","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115474_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.712511","article-title":"Phase I study to assess safety of laser-assisted topical administration of an anti-TNF biologic in patients with chronic plaque-type psoriasis","volume":"8","author":"Bauer","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115474_bb0805","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1208\/s12249-025-03199-0","article-title":"Novel pathways for non-invasive laser-assisted drug delivery: a critical review","volume":"26","author":"Singh","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115474_bb0810","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jid.2019.06.146","article-title":"Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0815","article-title":"Small extracellular vesicles derived from MSCs have immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120601","article-title":"Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-\u03baB decoy oligodeoxynucleotide","volume":"602","author":"Fukuta","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0825","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbi.2024.10.031","article-title":"An initial investigation of transcutaneous delivery of plasmid DNA encoding interleukin-10 for the treatment of psoriatic skin conditions","volume":"123","author":"Rocha","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0830","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-026-09154-6","article-title":"A comprehensive review of IL-10 and IL-10 receptor deficiencies: from basic science to clinical bedside","volume":"69","author":"Xiao","year":"2026","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123882","article-title":"In silico optimized cell-penetrating peptides achieve transdermal siRNA delivery and regulate inflammatory environment in psoriasis","volume":"328","author":"Wang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115474_bb0840","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/ced.15239","article-title":"The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis","volume":"47","author":"G\u00fcl","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0845","doi-asserted-by":"crossref","first-page":"eabb6049","DOI":"10.1126\/sciadv.abb6049","article-title":"Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations","volume":"6","author":"Mandal","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0850","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/exd.13722","article-title":"The human IL-17A\/F heterodimer regulates psoriasis-associated genes through I\u03baB\u03b6","volume":"27","author":"Bertelsen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0855","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2023.12.009","article-title":"Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions","volume":"365","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113581","article-title":"Dendritic lipopeptide-based transdermal siRNA delivery systems for effective non-invasive therapy in psoriasis","volume":"381","author":"Ma","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0865","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2022.09.014","article-title":"Lipopeptide liposomes-loaded hydrogel for multistage transdermal chemotherapy of melanoma","volume":"351","author":"Ni","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0870","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2147\/IJN.S504639","article-title":"Using siRNA-based anti-inflammatory lipid nanoparticles for gene regulation in psoriasis","volume":"20","author":"Zeng","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115474_bb0875","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2018.08.024","article-title":"Dendrimer as a new potential carrier for topical delivery of siRNA: a comparative study of dendriplex vs. lipoplex for delivery of TNF-\u03b1 siRNA","volume":"550","author":"Pandi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0880","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF-\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01469","article-title":"Application and mechanisms of triptolide in the treatment of inflammatory diseases\u2013a review","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123019","article-title":"Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs","volume":"640","author":"Silvestrini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb0895","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2017.10.034","article-title":"Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis","volume":"268","author":"Nemati","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0900","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303706","article-title":"Transcutaneous immunotherapy for RNAi: a cascade-responsive decomposable nanocomplex based on polyphenol-mediated framework nucleic acid in psoriasis","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120846","article-title":"Controllable assembly\/disassembly of polyphenol-DNA nanocomplex for cascade-responsive drug release in cancer cells","volume":"273","author":"Han","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115474_bb0910","first-page":"229","article-title":"Compensatory effect-based oxidative stress management microneedle for psoriasis treatment","volume":"46","author":"Wu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb0915","article-title":"Transdermal siRNA delivery via biomineralized nanoparticle-incorporated microneedles modulates cuproptosis-ferroptosis interaction for psoriasis therapy","volume":"37","author":"Hao","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115474_bb0920","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70425","article-title":"Cuproptosis facilitates chronic skin inflammation by regulating the \u03b1-ketoglutarate\/H3K4me3\/ferritin heavy chain 1 signaling pathway-mediated ferroptosis","volume":"6","author":"Yu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115474_bb0925","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.omtn.2019.11.013","article-title":"Fractional laser-mediated siRNA delivery for mitigating psoriasis-like lesions via IL-6 silencing","volume":"19","author":"Lee","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115474_bb0930","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jconrel.2022.05.032","article-title":"Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis","volume":"347","author":"Lee","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0940","doi-asserted-by":"crossref","first-page":"34449","DOI":"10.1021\/jacs.5c08376","article-title":"Strain-promoted mRNA transdermal delivery by lipoic lipid nanoparticles for therapeutic skin genome editing","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115474_bb0945","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1346-8138.15149","article-title":"Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"47","author":"Feng","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0955","article-title":"Perilla frutescens leaf-derived extracellular vesicle-like particles carry pab-miR396a-5p to alleviate psoriasis by modulating IL-17 signaling","volume":"8","author":"Liu","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.jconrel.2026.115474_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113664","article-title":"Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering","volume":"382","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb0970","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IJN.S441353","article-title":"Topical delivery of microRNA-125b by framework nucleic acids for psoriasis treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115474_bb0980","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2018.05.040","article-title":"Ultrasound targeting of Q-starch\/miR-197 complexes for topical treatment of psoriasis","volume":"284","author":"Zimon","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115474_bb1005","article-title":"Conjugation of gold nanoparticles to the anti-IL-17A aptamer improves anti-inflammatory effects of the aptamer in the experimental imiquimod-induced psoriasis","volume":"2025","author":"Khorrami","year":"2025","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.jconrel.2026.115474_bb1020","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1021\/acs.nanolett.5c02063","article-title":"Circularization of aptamer nanomedicine improves nuclease resistance, targeted recognition, and transdermal effect for topical psoriasis therapy","volume":"25","author":"Liu","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115474_bb1025","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1639869","article-title":"Comprehensive analysis of pyroptosis-related genes in psoriasis and targeted gene editing of CASP1 and CASP5 using lipid nanoparticles to alleviate skin inflammation","volume":"13","author":"Xu","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115474_bb1030","doi-asserted-by":"crossref","first-page":"eadl4336","DOI":"10.1126\/sciadv.adl4336","article-title":"Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders","volume":"10","author":"Tan","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb1050","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1021\/acsabm.5c01478","article-title":"Lipopolymeric nanoplex-mediated CRISPR\/Cas9 delivery for VEGF-A knockdown in psoriatic angiogenesis","volume":"8","author":"Tharmatt","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115474_bb1055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","volume":"7","author":"Wan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080356","article-title":"Insights on the use of \u03b1-lipoic acid for therapeutic purposes","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115474_bb0950","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2025.04.008","article-title":"Anti-inflammatory and antioxidative effects of Perilla frutescens-derived extracellular vesicles: insights from zebrafish models","volume":"182","author":"Huang","year":"2025","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0960","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12896-021-00683-w","article-title":"Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope","volume":"21","author":"Aslan","year":"2021","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.106771","article-title":"Quaternized starch: expanding the armamentarium for targeted delivery of diverse therapeutic payloads","volume":"107","author":"Fatima","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0985","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2022.11.005","article-title":"Selection and characterization of a new human interleukin-17A blocking DNA aptamer using protein-SELEX","volume":"637","author":"Shobeiri","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2026.115474_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108963","article-title":"Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model","volume":"110","author":"Shobeiri","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115474_bb0995","article-title":"Topical anti-TNF-\u03b1 ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB\/c mice","volume":"172","author":"hobeiri","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2026.115474_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/nano15151201","article-title":"Immunomodulatory effects of gold nanoparticles: impacts on immune cells and mechanisms of action","volume":"15","author":"Koushki","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2026.115474_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00857","article-title":"Antimicribial peptide LL-37 facilitates intracellular uptake of RNA aptamer Apt 21-2 without inducing an inflammatory or interferon response","volume":"10","author":"Macleod","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115474_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106314","article-title":"Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation","volume":"180","author":"Jin","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115474_bb1035","doi-asserted-by":"crossref","first-page":"eaaw8922","DOI":"10.1126\/sciadv.aaw8922","article-title":"A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing","volume":"5","author":"Liu","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115474_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122201","article-title":"Review of lipoic acid: from a clinical therapeutic agent to various emerging biomaterials","volume":"627","author":"Lv","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115474_bb1045","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.apsb.2022.12.013","article-title":"Intelligent nanotherapeutic strategies for the delivery of CRISPR system","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:52:10Z","timestamp":1793123530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":211,"alternative-id":["S0168365926008783"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115474","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115474"}}